"Biomarkers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc.
Descriptor ID |
D015415
|
MeSH Number(s) |
D23.101
|
Concept/Terms |
Biomarkers- Biomarkers
- Markers, Biological
- Biologic Markers
- Markers, Biologic
- Biologic Marker
- Marker, Biologic
- Marker, Biological
- Biological Marker
- Biological Markers
Serum Markers- Serum Markers
- Markers, Serum
- Marker, Serum
- Serum Marker
Surrogate Endpoints- Surrogate Endpoints
- Endpoints, Surrogate
- Surrogate End Points
- End Points, Surrogate
- Surrogate End Point
- End Point, Surrogate
- Surrogate Endpoint
- Endpoint, Surrogate
Viral Markers- Viral Markers
- Markers, Viral
- Viral Marker
- Marker, Viral
Biochemical Marker- Biochemical Marker
- Biochemical Markers
- Markers, Biochemical
- Marker, Biochemical
Markers, Immunologic- Markers, Immunologic
- Immune Markers
- Markers, Immune
- Marker, Immunologic
- Immunologic Markers
- Immune Marker
- Marker, Immune
- Immunologic Marker
Surrogate Markers- Surrogate Markers
- Markers, Surrogate
- Marker, Surrogate
- Surrogate Marker
|
Below are MeSH descriptors whose meaning is more general than "Biomarkers".
Below are MeSH descriptors whose meaning is more specific than "Biomarkers".
This graph shows the total number of publications written about "Biomarkers" by people in this website by year, and whether "Biomarkers" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1993 | 0 | 1 | 1 |
1995 | 0 | 2 | 2 |
1996 | 0 | 1 | 1 |
1997 | 0 | 1 | 1 |
2000 | 0 | 4 | 4 |
2002 | 0 | 2 | 2 |
2003 | 0 | 4 | 4 |
2004 | 2 | 10 | 12 |
2005 | 1 | 4 | 5 |
2006 | 0 | 8 | 8 |
2007 | 0 | 5 | 5 |
2008 | 0 | 5 | 5 |
2009 | 0 | 12 | 12 |
2010 | 2 | 16 | 18 |
2011 | 3 | 13 | 16 |
2012 | 3 | 21 | 24 |
2013 | 3 | 21 | 24 |
2014 | 3 | 19 | 22 |
2015 | 2 | 22 | 24 |
2016 | 5 | 29 | 34 |
2017 | 0 | 38 | 38 |
2018 | 8 | 32 | 40 |
2019 | 2 | 45 | 47 |
2020 | 2 | 40 | 42 |
2021 | 1 | 26 | 27 |
2022 | 0 | 28 | 28 |
2023 | 0 | 7 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Biomarkers" by people in Profiles.
-
Discovery and validation of circulating stroke metabolites by NMR-based analyses using patients from the MISS and UK Biobank. Neurochem Int. 2023 Oct; 169:105588.
-
Difference in acute and chronic stage ischemic stroke metabolic markers with controls. J Stroke Cerebrovasc Dis. 2023 Aug; 32(8):107211.
-
miR-18a and miR-106a Signatures in Plasma Small EVs Are Promising Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma. Int J Mol Sci. 2023 Apr 13; 24(8).
-
Transforming Growth Factor Beta 1 as a Potential Biomarker in Children With Sickle Cell Disease. J Pediatr Hematol Oncol. 2023 May 01; 45(4):225-226.
-
Anti-vimentin antibodies are associated with higher severity of Sj?gren's disease. Clin Immunol. 2023 02; 247:109243.
-
A Review of the Diagnosis and Treatment of Necrotizing Enterocolitis. Curr Pediatr Rev. 2023; 19(3):285-295.
-
A kidney resident macrophage subset is a candidate biomarker for renal cystic disease in preclinical models. Dis Model Mech. 2023 01 01; 16(1).
-
Biomarkers of necrotizing enterocolitis in the era of machine learning and omics. Semin Perinatol. 2023 02; 47(1):151693.
-
Association between Serum Biomarkers with Postoperative Complications and Delay of Adjuvant Chemotherapy Initiation in Ovarian Cancer Patients Undergoing Primary Cytoreductive Surgery: A Pilot Study. Nutr Cancer. 2023; 75(2):662-669.
-
MiR-205-5P AS POTENTIAL BIOMARKER AND THERAPEUTIC TARGET IN HEAD AND NECK SQUAMOUS CELL CARCINOMA. Exp Oncol. 2022 12; 44(4):337-338.